EQ (Equillium) FFO


EQ Equillium Inc EQ
28 GF Score
Price $2.88
GF Value $0.10
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Equillium FFO?

FFO (Funds from operations) only applies to REITs.

EQ
28GF Score
Equillium Inc EQ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Equillium (EQ) Overvalued in 2026?

Based on GuruFocus' analysis, Equillium stock appears to be overvalued. The current stock price of $2.88 is trading 2775% above its estimated GF Value™ of $0.10. GuruFocus considers Equillium to be Significantly Overvalued.

Key valuation signals for EQ:

  • FFO:
  • GF Value™: $0.10 vs. price of $2.88 (2775% above fair value)
  • GF Score™: 28/100 with 3 warning signs

No single metric tells the full story. See the EQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Equillium Business Description

Other Exchanges 0A4D:UK0FY:Germany
Address 2223 Avenida De La Playa, Suite 105, La Jolla, CA, USA, 92037
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
28GF Score

Get the complete analysis for EQ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.88
Price
$0.10
GF Value